-
Product Insights
JAKS Solar PV Park
JAKS Solar PV Park is a solar PV project located in Penang, Malaysia. The project is owned and being developed by JAKS Resources Berhad. The project is at the permitting stage. Empower your strategies with our JAKS Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval Analysis for Thrombocythemia Myelofibrosis
Overview How likely is it that the drugs in Thrombocythemia Myelofibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thrombocythemia Myelofibrosis Overview Essential thrombocythemia (ET) is a rare blood cancer that...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lorpucitinib in Familial Adenomatous Polyposis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lorpucitinib in Familial Adenomatous Polyposis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lorpucitinib in Familial Adenomatous Polyposis Drug Details: Lorpucitinib is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AZD-4604 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AZD-4604 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AZD-4604 in Asthma Drug Details: AZD-4604 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib in Ulcerative Colitis Drug Details: Tofacitinib (PGN-600) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – KN-002 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KN-002 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KN-002 in Asthma Drug Details: KN-002(formerly known as VR-588) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Atopic Dermatitis (Atopic Eczema) Drug Details: Delgocitinib (Corectim)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Alopecia Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Psoriasis Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Hand Dermatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Hand Dermatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Hand Dermatitis Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent....